Inogenix
Chuncheon, South Korea
INOGENIX is a molecular diagnostic company based in South Korea, founded in 2019, that develops innovative medical devices. They focus on creating solutions for early disease detection, personalized medicine, and improved patient outcomes. Their products utilize AI-based technology and target various diseases like coronavirus, colorectal cancer, tuberculosis, and sepsis, among others.
Company Info
- Founded
- 2019
- Website
- www.inogenix.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Inogenix?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.